Accelerate range

The best way to heal

  • Speeds up wound healing
  • Is cost-effective
  • Improves patients' quality of life

picto_purify_nb picto_clean_nb picto_accelerate picto_close_nb

 

 

 

Accelerate the wound healing process

Principle

Accelerate range is not available in Philippines yet

Leg ulcers, pressure ulcers and diabetic foot ulcers are common wound types and part of the day-to-day reality for healthcare professionals. In response to this problem, Urgo has developed the UrgoStart range which is clinically proven to accelerate the wound-healing process, once the wound is clean and prepared for healing.

 

Mode of action

The TLC-NOSF in UrgoStart neutralises the excess proteases present in chronic wounds. This rebalances the wound equilibrium and promotes faster healing. TLC (Technology Lipido-Colloid) creates a moist environment, promotes fibroblast proliferation and ensures non-adherence and pain-free dressing change.

 

TLC NOSF Technology

Indications

Leg ulcers, pressure ulcers, diabetic foot ulcers and longstanding acute wounds.

 

accelerate01 

Contra-indications

In order not to delay any optimal treatment, UrgoStart is contraindicated in wounds such as cancerous wounds or fistula wounds which may reveal a deep abscess.

 

Key benefits

  • Promotes faster healing (1)
  • Is cost-effective
  • Improves patients’ quality of life (1)

 

Range

 

Click here to learn more about UrgoStart Contact and UrgoStart.

 

range_accelerate

 

Clinical evidence

For a review of the clinical evidence for TLC-NOSF dressings please click here

(1) Meaume S, et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair and Regeneration 2012 (July/August);Vol 20:500-511.

Last update : June 9, 2015